Cat.#: ACPP-1828
Despition | EPHA2 Human Recombinant |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 95%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1751 | Human HAGH Protein (AC1751) | 2 µg | inquiry |
ACPP-1731 | Human DNAJC19 Protein (AC1731) | 2 µg | inquiry |
ACPP-1034 | Recombinant Human NG2 Protein (6×His Tag) (AC1034) | 50 µg | inquiry |
ACPP-1508 | Human I TAC Protein (AC1508) | 5 µg | inquiry |
ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.